These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1607000)

  • 21. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
    Thalhammer F; Hörl WH
    Clin Pharmacokinet; 2000 Oct; 39(4):271-9. PubMed ID: 11069213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis.
    Lorusso V; Taroni P; Alvino S; Spinazzi A
    Invest Radiol; 2001 Jun; 36(6):309-16. PubMed ID: 11410750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of meropenem and its metabolite in young and elderly healthy men.
    Ljungberg B; Nilsson-Ehle I
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1437-40. PubMed ID: 1510440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of habekacin in patients with renal insufficiency.
    Fillastre JP; Leroy A; Humbert G; Moulin B; Bernadet P; Josse S
    Antimicrob Agents Chemother; 1987 Apr; 31(4):575-7. PubMed ID: 3606062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teicoplanin pharmacokinetics in patients with chronic renal failure.
    Bonati M; Traina GL; Villa G; Salvadeo A; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Clin Pharmacokinet; 1987 Apr; 12(4):292-301. PubMed ID: 2954735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole.
    Toon S; Ross CE; Gokal R; Rowland M
    Br J Clin Pharmacol; 1990 Feb; 29(2):221-6. PubMed ID: 2306414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.
    Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K
    Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between renal function and disposition of oral cefixime.
    Dhib M; Moulin B; Leroy A; Hameau B; Godin M; Johannides R; Fillastre JP
    Eur J Clin Pharmacol; 1991; 41(6):579-83. PubMed ID: 1815970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reassessment of the single intravenous injection method with inulin for measurement of the glomerular filtration rate in man.
    Prescott LF; Freestone S; McAuslane JA
    Clin Sci (Lond); 1991 Feb; 80(2):167-76. PubMed ID: 1848170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of haemodialysis on metoclopramide kinetics in patients with severe renal failure.
    Wright MR; Axelson JE; Rurak DW; McErlane B; McMorland GH; Ongley RC; Tam YK; Price JD
    Br J Clin Pharmacol; 1988 Oct; 26(4):474-7. PubMed ID: 3190998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.
    Singlas E; Taburet AM; Landru I; Albin H; Ryckelinck JP
    Eur J Clin Pharmacol; 1987; 31(5):589-93. PubMed ID: 3830244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of intravenous amdinocillin in healthy subjects and patients with renal insufficiency.
    Patel IH; Bornemann LD; Brocks VM; Fang LS; Tolkoff-Rubin NE; Rubin RH
    Antimicrob Agents Chemother; 1985 Jul; 28(1):46-50. PubMed ID: 4037777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of meropenem after the first and tenth intramuscular administration.
    Novelli A; Mazzei T; Meli E; Conti S; Fallani S; Periti P
    J Antimicrob Chemother; 1996 Apr; 37(4):775-81. PubMed ID: 8722543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meropenem clinical pharmacokinetics.
    Mouton JW; van den Anker JN
    Clin Pharmacokinet; 1995 Apr; 28(4):275-86. PubMed ID: 7648757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.